Attenborough Medical
0794.989.531 · rovalta.com · 26/09/2026
Attenborough Medical
Financial year 2025 · Closed on 30/04/2025
Overview
Identity
Source · BCE/KBOAttenborough Medical is a Private limited company incorporated in 2022. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Lokeren. It employs on average 1,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0794.989.531
- Incorporation
- 19/12/2022
- Legal form
- Private limited company
- Registered office
- Mosten 13
9160 Lokeren · FlandreSee on map - Contributed capital
- 10 000,00 €
- Latest accounts
- 30/04/2025
- Average workforce
- 1,0 ETP
Joint committees (1)
- 20900
Financials
Source · NBB, 3 filingsTrend over 3 financial years
| 2025 | 2024 | 2023 | |||
|---|---|---|---|---|---|
| Income statement | |||||
| Gross margin | 38 k € | -40.9% | 64,3 k € | +1063% | 5,5 k € |
| EBITDA | -19 k € | +27.4% | -26,1 k € | -175% | -9,5 k € |
| Operating result | -24,6 k € | +17.4% | -29,9 k € | -209% | -9,7 k € |
| Net result | -24,7 k € | +17.6% | -30 k € | -210% | -9,7 k € |
| Balance sheet | |||||
| Equity | -54,4 k € | -83.3% | -29,7 k € | -9269% | 323,4 € |
| Total assets | 132,9 k € | -23.2% | 173,1 k € | +487% | 29,5 k € |
| Cash | 11,3 € | -100.0% | 40,8 k € | +2573% | 1,5 k € |
| Debts | 187,3 k € | -7.6% | 202,8 k € | +595% | 29,2 k € |
| Other | |||||
| Workforce | 1,0 ETP | -23.1% | 1,3 ETP | – | |
Board of directors
Source · NBB, accounts to 30/04/20252 active
Active mandates
Other companies at this address
Mosten 13 9160 Lokeren| Company | CBE no. |
|---|---|
Confirma● Active | 0695.756.947 |
ENGIPLAST● Active | 0866.458.339 |
GROUP PENNEMAN● Active | 0819.247.152 |
OnCourt EU● Active | 0775.310.211 |
ProCenTis● Active | 0815.860.763 |
RSI Sports Panels● Active | 0546.759.504 |
TECNAU● Active | 0867.437.841 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/05/2024 | 01/05/2023 | 01/01/2023 |
| Closing of the financial year | 30/04/2025 | 30/04/2024 | 30/04/2023 |
| Length of the financial year | 12 months | 12 months | 4 months |
| Filing date | 14/04/2026 | 27/03/2026 | 21/12/2023 |
| General meeting | 18/02/2026 | 24/10/2025 | 31/10/2023 |
| Currency of the financial year | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 3 filingsValuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/04/20252 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other21/12/2022RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-24,7 k €↑
- 2024Annual accounts 2024-30 k €↓
- 2023Annual accounts 2023-9,7 k €
- 19/12/2022IncorporationPrivate limited company